FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045330558> ?p ?o ?g. }

• W2045330558 endingPage "320" @default.
• W2045330558 startingPage "314" @default.
• W2045330558 abstract "Advanced follicular lymphomas (FL) are considered incurable with conventional chemotherapy and there is no consensus on the best treatment approach. Southwest Oncology Group (SWOG) and Cancer and Leukemia Group B compared the safety and efficacy of two immunochemotherapy regimens for FL in a phase III randomized intergroup protocol (SWOG S0016) that enrolled 554 patients with previously untreated, advanced-stage FL between March 1, 2001, and September 15, 2008.Patients were eligible for the study if they had advanced-stage (bulky stage II, III, or IV) evaluable FL of any grade (1, 2, or 3) and had not received previous therapy. In one arm of the study, patients received six cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy at 3-week intervals with six doses of rituximab (CHOP-R). In another arm of the study, patients received six cycles of CHOP followed by consolidation with tositumomab/iodine I-131 tositumomab radioimmunotherapy (RIT).After a median follow-up period of 4.9 years, the 2-year estimate of progression-free survival (PFS) was 76% on the CHOP-R arm and 80% on the CHOP-RIT arm (P = .11). The 2-year estimate of overall survival (OS) was 97% on the CHOP-R arm and 93% on the CHOP-RIT arm (P = .08).There was no evidence of a significant improvement in PFS comparing CHOP-RIT with CHOP-R. However, PFS and OS were outstanding on both arms of the study. Future studies are needed to determine the potential benefits of combining CHOP-R induction chemotherapy with RIT consolidation and/or extended rituximab maintenance therapy." @default.
• W2045330558 created "2016-06-24" @default.
• W2045330558 creator A5004025497 @default.
• W2045330558 creator A5009574158 @default.
• W2045330558 creator A5009883349 @default.
• W2045330558 creator A5014743270 @default.
• W2045330558 creator A5016684714 @default.
• W2045330558 creator A5025865972 @default.
• W2045330558 creator A5038526399 @default.
• W2045330558 creator A5041539801 @default.
• W2045330558 creator A5064449830 @default.
• W2045330558 creator A5065474674 @default.
• W2045330558 creator A5076637635 @default.
• W2045330558 creator A5078791373 @default.
• W2045330558 creator A5080366682 @default.
• W2045330558 creator A5082606841 @default.
• W2045330558 creator A5091192260 @default.
• W2045330558 date "2013-01-20" @default.
• W2045330558 modified "2023-10-16" @default.
• W2045330558 title "Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus ¹³¹Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016" @default.
• W2045330558 cites W1563765846 @default.
• W2045330558 cites W1912693401 @default.
• W2045330558 cites W1921508210 @default.
• W2045330558 cites W2001302091 @default.
• W2045330558 cites W2014145299 @default.
• W2045330558 cites W2014654561 @default.
• W2045330558 cites W2045209749 @default.
• W2045330558 cites W2048743906 @default.
• W2045330558 cites W2058015212 @default.
• W2045330558 cites W2061272096 @default.
• W2045330558 cites W2092101307 @default.
• W2045330558 cites W2100167053 @default.
• W2045330558 cites W2101141816 @default.
• W2045330558 cites W2101648653 @default.
• W2045330558 cites W2114233385 @default.
• W2045330558 cites W2127249281 @default.
• W2045330558 cites W2132443196 @default.
• W2045330558 cites W2133201432 @default.
• W2045330558 cites W2134090290 @default.
• W2045330558 cites W2134566706 @default.
• W2045330558 cites W2135321054 @default.
• W2045330558 cites W2141681661 @default.
• W2045330558 cites W2143168735 @default.
• W2045330558 cites W2144016324 @default.
• W2045330558 cites W2147581636 @default.
• W2045330558 cites W2149250280 @default.
• W2045330558 cites W2153921055 @default.
• W2045330558 cites W2154643481 @default.
• W2045330558 cites W2159982513 @default.
• W2045330558 cites W2160305510 @default.
• W2045330558 cites W2168926834 @default.
• W2045330558 cites W2169578616 @default.
• W2045330558 cites W4293203547 @default.
• W2045330558 cites W4293241248 @default.
• W2045330558 cites W4365787119 @default.
• W2045330558 doi "https://doi.org/10.1200/jco.2012.42.4101" @default.
• W2045330558 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3732010" @default.
• W2045330558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23233710" @default.
• W2045330558 hasPublicationYear "2013" @default.
• W2045330558 type Work @default.
• W2045330558 sameAs 2045330558 @default.
• W2045330558 citedByCount "147" @default.
• W2045330558 countsByYear W20453305582012 @default.
• W2045330558 countsByYear W20453305582013 @default.
• W2045330558 countsByYear W20453305582014 @default.
• W2045330558 countsByYear W20453305582015 @default.
• W2045330558 countsByYear W20453305582016 @default.
• W2045330558 countsByYear W20453305582017 @default.
• W2045330558 countsByYear W20453305582018 @default.
• W2045330558 countsByYear W20453305582019 @default.
• W2045330558 countsByYear W20453305582020 @default.
• W2045330558 countsByYear W20453305582021 @default.
• W2045330558 countsByYear W20453305582022 @default.
• W2045330558 countsByYear W20453305582023 @default.
• W2045330558 crossrefType "journal-article" @default.
• W2045330558 hasAuthorship W2045330558A5004025497 @default.
• W2045330558 hasAuthorship W2045330558A5009574158 @default.
• W2045330558 hasAuthorship W2045330558A5009883349 @default.
• W2045330558 hasAuthorship W2045330558A5014743270 @default.
• W2045330558 hasAuthorship W2045330558A5016684714 @default.
• W2045330558 hasAuthorship W2045330558A5025865972 @default.
• W2045330558 hasAuthorship W2045330558A5038526399 @default.
• W2045330558 hasAuthorship W2045330558A5041539801 @default.
• W2045330558 hasAuthorship W2045330558A5064449830 @default.
• W2045330558 hasAuthorship W2045330558A5065474674 @default.
• W2045330558 hasAuthorship W2045330558A5076637635 @default.
• W2045330558 hasAuthorship W2045330558A5078791373 @default.
• W2045330558 hasAuthorship W2045330558A5080366682 @default.
• W2045330558 hasAuthorship W2045330558A5082606841 @default.
• W2045330558 hasAuthorship W2045330558A5091192260 @default.
• W2045330558 hasBestOaLocation W20453305582 @default.
• W2045330558 hasConcept C126322002 @default.
• W2045330558 hasConcept C141071460 @default.
• W2045330558 hasConcept C143998085 @default.
• W2045330558 hasConcept C159654299 @default.
• W2045330558 hasConcept C203014093 @default.
• W2045330558 hasConcept C2776146153 @default.
• W2045330558 hasConcept C2776694085 @default.

• next